ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: FR-PO126

Targeted Ablation of Distal Cerebrospinal Fluid-Contacting Nucleus Alleviated Renal Fibrosis in CKD

Session Information

Category: CKD (Non-Dialysis)

  • 1903 CKD (Non-Dialysis): Mechanisms

Authors

  • Qiu, Minzi, Nanfang Hospital, Southern Medical University, Guangzhou, GUANGDONG, China
  • Li, Jiawen, Nanfang Hospital, Southern Medical University, Guangzhou, GUANGDONG, China
  • Tan, Lishan, Nanfang Hospital, Southern Medical University, Guangzhou, GUANGDONG, China
  • Li, Aiqing, Nanfang Hospital, Southern Medical University, Guangzhou, GUANGDONG, China
Background

The distal cerebrospinal fluid-contacting nucleus (dCSF-CNs) is thought to be a linkage between the cerebrospinal fluid and brain. The potential function of dCSF-CNs in development of CKD is poorly understood. We hypothesized that dCSF-CNs might exert a signaling transmission effect on the cascade reaction of renin-angiotensin system (RAS) in the progression of kidney injury, and that ablation of the dCSF-CNs might alleviate the local RAS and renal fibrosis in five-sixths nephrectomied (5/6Nx) rat model.

Methods

Rats were subjected to intracerebroventricular (icv) administration of artificial cerebrospinal fluid (aCSF) followed by five-sixths nephrectomied or sham operation, or icv administration of Cholera toxin subunit B conjugated with saporin (CB-SAP) for dCSF-CNs lesion before five-sixths nephrectomied. The effect of CB-SAP treatment on ablation of dCSF-CNs was confirmed via double immunofluorescence staining. The expression levels of RAS components, NOX2 and c-fos in SFO, PVN and hippocampus, as well as the numbers of Tyrosine Hydroxilase and c-fos positive cells in RVLM were detected. The expression levels of RAS components (AGT, ACE, AT1R, ACE2, Mas receptor), NADPH oxidase (NOX2, catalase), inflammatory cytokines (MCP-1, IL-6), fibrotic readouts (fibronectin, collagen I) in kidney were compared.

Results

Compared with 5/6Nx rats, the number of CB-labelled neurons in dCSF-CNs decreased in CB-SAP treated rats. Treatment with CB-SAP down-regulated the expression levels of RAS components (AGT, Ang II, AT1R), NADPH oxidase (NOX2, catalase), inflammatory cytokines (MCP-1, IL-6), fibrotic readouts (fibronectin, collagen I) in rats, and up-regulated the protein levels of ACE2 and Mas receptor, compared with CKD rats. Increased numbers of Tyrosine Hydroxilase and c-fos positive cells were observed in the RVLM of 5/6Nx rats, but that were decrease under the influence of ablation of dCSF-CNs.

Conclusion

Targeted ablation of the dCSF-CNs might alleviate renal inflammation and fibrosis in the development of chronic kidney injury through inhibiting activation of inhibit the cerebral and renal RAS/ NADPH oxidase.

Funding

  • Government Support - Non-U.S.